BIT's 12th Annual World Cancer Congress-2019(WCC-2019)
★ Scientific Program

Preliminary Program


Session times on those days will not be finalized until the overall program schedule is completed.

Program Tracks (Please click each Track for detailed program information)

Opening Ceremony and Keynote Forum

Track 1: Recent Advances in Cancer Research

Track 2: Breakthroughs in Cancer Prognostics and Diagnostics

Track 3: Best Practice on Clinical Oncology

Track 4: Clinical Research

Track 5: Novel Approaches to Cancer Therapeutics

Track 6: Cancer Epidemiology and Prevention


Opening Ceremony and Keynote Forum

Time: 09:30-12:15, May 15, 2019 (Wednesday)


Call for Moderator


Moderator's Introduction


Speech Opportunity Available


Title: Personalized Cancer Therapy in The Area of Cell Based Therapy
Dr. Stefan J. Scherer, VP & Head Early Development, Strategy and Innovation, Novartis, USA


Title: TBD
Dr. Vladimir Lazar, Chief Scientific and Operating Officer, WIN Consortium, France


Title: Nanozymes: A New Strategy for Tumor Therapy
Dr. Xiyun Yan, Professor, Chinese Academy of Sciences, China


Title: TBD
Dr. Gerard L. Hanley,
Assistant Vice Chancellor, Academic Technology Services; Executive Director, MERLOT, California State University, USA


Title: Blincyto®: The First Approved BiTE® Antibody Construct
Dr. Benno Rattel, Executive Director, Nonclinical Development ARM, AMGEN Research (Munich) GmbH, Germany

Hosting Organization

BIT Group Global Ltd.

Supporting Organization
International Honorary Chairmen

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2008-2019 BIT Congress Inc.